Asian Journal Of Social Pharmacy

Asian Journal of Social Pharmacy

20 June 2017, Volume 12 Issue 2 Previous Issue    Next Issue

Application of SWOT Analysis and Porter’s Five Forces Analysis to State-owned Enterprise Affiliated Hospitals in China

Wang Tao, Wu Zhi’ang, Li Shuchuen

2017, 12 (2): 41–49;

Abstract ( 1040 ) PDF (486KB) ( 1340 )

Measures to Speed up Drug Review Process in Japan and Its Implications

Shi Wenwen, Sun Lihua

2017, 12 (2): 50–56;

Abstract ( 520 ) PDF (571KB) ( 2616 )

Analysis of New Drug Registration for Biological Products from 2010 to 2015 in China

Liu Dandan, Chen Yuwen

2017, 12 (2): 57–63;

Abstract ( 409 ) PDF (652KB) ( 1040 )

Problems of Fake Anti-malarial Drugs in Cambodia

Tem Darina, Mao Ningying

2017, 12 (2): 64–70;

Abstract ( 447 ) PDF (606KB) ( 743 )

Management of Subjects in Phase I Clinical Trials for New Drug

Qian Cuihong, Lian Guiyu

2017, 12 (2): 71–73;

Abstract ( 386 ) PDF (376KB) ( 685 )

Research on Economic Evaluation of Rare Diseases

Li Tongtong, Zhang Fang

2017, 12 (2): 74–80;

Abstract ( 375 ) PDF (531KB) ( 574 )

Influence Factors on Psychological Empowerment of Pharmaceutical Sales Representatives

Pan Shuang, Wu Zhi’ang

2017, 12 (2): 81–87;

Abstract ( 435 ) PDF (504KB) ( 733 )